|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02197 CLOVER BIO-B
Nominal 
0.250 +0.001 (+0.402%) | 2024/06 - Interim RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | (727,878) | (1,690,809) | (917,749) | 476,927 |
| Net Cash from / (used in) Investing Activities | -- | (6,161) | (37,506) | 112,124 | (394,120) |
| Net Cash from / (used in) Financing Activities | -- | (142,408) | 483,143 | 3,057,173 | 316,847 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | (876,447) | (1,245,172) | 2,251,548 | 399,654 |
| Cash & Cash Equivalents at beginning of period | -- | 1,607,409 | 2,767,371 | 516,184 | 148,694 |
| Effect of Foreign Exchange Rate Changes | -- | 4,902 | 85,210 | (361) | (32,164) |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 735,864 | 1,607,409 | 2,767,371 | 516,184 |
| Remarks: | Real time quote last updated: 24/12/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -95,123,000 |
| %Change | -- |
| EPS / (LPS) | RMB -0.080 |
| NBV Per Share (¥) | RMB -0.642 |